Steve Jobs doomed himself to early death - doctor

Steve Jobs doomed himself to early death - doctor

PanARMENIAN.Net - Steve Jobs would probably be alive today if he had not put off conventional medical treatment in favor of alternative remedies, a leading cancer doctor has said.

Dr Ramzi Amri, a researcher at Harvard Medical School, claims the Apple boss had a mild form of cancer that is rarely fatal and that his choice of treatment 'eventually led to an unnecessarily early death'.

Writing on Quora, a forum frequented by Silicon Valley executives, Dr Amri said: “Let me cut to the chase - Mr Jobs allegedly chose to undergo all sorts of alternative treatment options before opting for conventional medicine. Given the circumstances, it seems sound to assume that Mr Jobs' choice for alternative medicine has eventually led to an unnecessarily early death.”

Mr Jobs died earlier this month due to respiratory arrest caused by pancreatic cancer. He was 56.

His death certificate, released by the Santa Clara County Public Health Department this week, said that Mr Jobs had a 'metastatic pancreas neuroendocrine tumor' and there would not be an autopsy.

The certificate also stated that Mr Jobs had the cancer for eight years before his death and that he was first diagnosed in October 2003.

Dr Amri claimed that Mr Jobs succumbed to the disease more quickly because of his apparent refusal to embrace 'conventional treatment', especially over the last year, the period when he visibly began to lose weight, Daily Mail reported.

 Top stories
Authorities said a total of 192 Azerbaijani troops were killed and 511 were wounded during Azerbaijan’s offensive.
In 2023, the Azerbaijani government will increase the country’s defense budget by more than 1.1 billion manats ($650 million).
The bill, published on Monday, is designed to "eliminate the shortcomings of an unreasonably broad interpretation of the key concept of "compatriot".
The earthquake caused a temporary blackout, damaged many buildings and closed a number of rural roads.
Partner news
---